Enables several functions, including identical protein binding activity; platelet-derived growth factor binding activity; and protease binding activity. Involved in several processes, including collagen fibril organization; skin morphogenesis; and transforming growth factor beta receptor signaling pathway. Located in extracellular space. Part of collagen type I trimer. Implicated in Ehlers-Danlos syndrome (multiple); heart valve disease; intracranial aneurysm; osteogenesis imperfecta (multiple); and osteoporosis.
alpha 2 type I procollagen; alpha 2(I) procollagen; alpha 2(I)-collagen; alpha-2 type I collagen; collagen alpha-2(I) chain; collagen I, alpha-2 polypeptide; collagen of skin, tendon and bone, alpha-2 chain; collagen type I alpha 2; collagen, type I, alpha 2; EDSARTH2; EDSCV; OI4; type I procollagen
N-(4-chlorophenyl)-1-((3-(furan-2-yl)phenyl)carbonyl)piperidine-3-carboxamide inhibits the reaction [lysophosphatidic acid results in increased expression of COL1A2 mRNA]
[Estradiol co-treated with Progesterone] results in increased expression of COL1A2 mRNA and [Estradiol co-treated with TGFB1 protein] results in increased expression of COL1A2 mRNA
6-diphenylmethyl-5-(5-isopropyl-2-methoxybenzylamino)-1-azabicyclo(2.2.2)octane-3-carboxylic acid inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of COL1A2 mRNA] more ...
acetovanillone inhibits the reaction [AGT protein results in increased expression of COL1A2 mRNA] and acetovanillone inhibits the reaction [AGT protein results in increased expression of COL1A2 protein]
[sodium arsenite results in increased abundance of arsenite] which results in increased expression of COL1A2 protein and Dietary Fats promotes the reaction [arsenite results in increased expression of COL1A2 mRNA]
[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of COL1A2 mRNA and [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of COL1A2 mRNA
[NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with Dietary Fats] results in increased expression of COL1A2 mRNA and [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of COL1A2 mRNA
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with Dietary Fats] results in increased expression of COL1A2 mRNA more ...
Chenodeoxycholic Acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of COL1A2 mRNA]
[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL1A2 mRNA more ...
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA
[Disulfiram binds to Copper] which results in increased expression of COL1A2 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of COL1A2 mRNA
[Disulfiram binds to Copper] which results in increased expression of COL1A2 mRNA and [NSC 689534 binds to Copper] which results in decreased expression of COL1A2 mRNA
ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of COL1A2 mRNA] and TLR4 gene mutant form inhibits the reaction [Cyclosporine results in increased expression of COL1A2 mRNA]
[Arsenic Trioxide co-treated with Ascorbic Acid] results in increased expression of COL1A2 mRNA and [Tetradecanoylphorbol Acetate co-treated with Arsenic Trioxide] results in increased expression of COL1A2 mRNA
[Dimethyl Sulfoxide co-treated with TGFB1 protein] results in increased expression of COL1A2 mRNA and LY-2157299 inhibits the reaction [[Dimethyl Sulfoxide co-treated with TGFB1 protein] results in increased expression of COL1A2 mRNA]
[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL1A2 mRNA more ...
[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of COL1A2 mRNA more ...
[NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A2 mRNA] more ...
[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of COL1A2 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of COL1A2 mRNA
[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of COL1A2 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of COL1A2 mRNA
[Imatinib Mesylate co-treated with Perindopril] inhibits the reaction [Carbon Tetrachloride affects the expression of COL1A2 mRNA] and Perindopril inhibits the reaction [Carbon Tetrachloride affects the expression of COL1A2 mRNA]
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of COL1A2 mRNA and [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of COL1A2 mRNA
atractylodin promotes the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of COL1A2 mRNA]] more ...
resveratrol inhibits the reaction [DMD gene mutant form results in increased expression of COL1A2 mRNA] and resveratrol inhibits the reaction [IGF1 protein results in increased expression of COL1A2 mRNA]
SB 203580 inhibits the reaction [cobaltous chloride results in increased expression of COL1A2 mRNA] and SB 203580 inhibits the reaction [cobaltous chloride results in increased expression of COL1A2 protein]
selenomethylselenocysteine results in decreased expression of COL1A2 mRNA and selenomethylselenocysteine results in decreased expression of COL1A2 protein
selenomethylselenocysteine results in decreased expression of COL1A2 mRNA and selenomethylselenocysteine results in decreased expression of COL1A2 protein
geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of COL1A2 mRNA] and geranylgeranylacetone inhibits the reaction [Bleomycin results in increased expression of COL1A2 protein]
1-trifluoromethoxyphenyl-3-(1-propionylpiperidine-4-yl)urea inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A2 mRNA] more ...
[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of COL1A2 mRNA
Thalidomide inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A2 mRNA] and Thalidomide inhibits the reaction [TNF protein results in increased expression of COL1A2 mRNA]
[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
[NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of COL1A2 mRNA
Y 27632 inhibits the reaction [ABCB4 gene mutant form results in increased expression of COL1A2 mRNA] and Y 27632 inhibits the reaction [Oxygen results in increased expression of COL1A2 mRNA]